Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Poll

More »
Apr 06, 2012

Biofacility Construction

How confident are you that Massachusetts can sustain its biopharma construction boom?

Very
 
  60.3%
Somewhat
 
  23.8%
Not Very
 
  11.1%
Undecided
 
  4.8%

Suggest a Poll
More Polls » View Results »

Pfizer, Novartis, and Shire are among nearly a dozen biopharma companies, research institutions, and developers building a combined 3.5 million plus square feet of lab and office space totaling more than $2 billion across Massachusetts. The list also includes research institutions like Broad Institute and developers like Alexandria Real Estate Equities. While companies are growing, with aided incentives like tax breaks, Massachusetts will face increasing competition from global emerging markets with their own incentives such as lower wages and less regulatory red tape.

GEN Poll

More » Poll Results Ā» Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll